全球人口健康管理(PHM)市場:按組件(軟件,服務),交付方式(本地,雲端),用戶(醫療保健組織(醫院,ACO),醫療支付者,雇主團體,政府機構)預測至2027
市場調查報告書
商品編碼
1136866

全球人口健康管理(PHM)市場:按組件(軟件,服務),交付方式(本地,雲端),用戶(醫療保健組織(醫院,ACO),醫療支付者,雇主團體,政府機構)預測至2027

Population Health Management (PHM) Market by Component (Software, Services), Mode of Delivery (On-premise, Cloud-based), End User (Healthcare Providers (Hospitals, ACOs), Healthcare Payers, Employer Groups, Government Bodies) - Global Forecast to 2027

出版日期: | 出版商: MarketsandMarkets | 英文 201 Pages | 訂單完成後即時交付

價格
簡介目錄

全球集體醫療保健市場預計將從 2022 年的 278 億美元增至 2027 年的 533 億美元,預測期內的複合年增長率為 13.9%。

市場的主要驅動力包括政府加大力度改善當地社區的醫療保健、患者人數不斷增加、老年人口不斷增加,以及控制醫療保健成本的需求增加。然而,熟練 IT 專業人員的短缺和高基礎設施投資預計將在一定程度上抑制該市場的增長。

按組件劃分,軟件細分市場預計將是最大的細分市場,並在預測期內實現最高增長。該細分市場的增長動力是運營效率的提高、硬件方面的前期投資以及與增強患者參與度相關的軟件採用率的增加。

按最終用戶計算,醫療保健提供商細分市場預計將在 2021 年以最高速度增長。控制醫療保健成本的日益增長的需求、對更好財務結果的日益增長的需求以及 ACA 的授權預計將推動未來的需求。

按地區劃分,預計亞太地區在預測期內將以最高的複合年增長率增長。亞太地區的市場增長主要受到以下因素的推動:醫療基礎設施的改善、醫療旅遊的擴張、政府引入 HCIT 的努力、醫療成本上升以及消費者購買力的提高。

本報告按組件、交付方式、最終用戶和地區分析了全球人口健康管理 (PHM) 市場,包括市場基本結構和當前發展、主要市場驅動因素和限制因素。市場趨勢展望,市場競爭狀況、主要參與者概況等。

內容

第一章介紹

第二章研究方法

第 3 章執行摘要

第 4 章重要注意事項

第 5 章市場概述

  • 簡介
  • 市場動態

第 6 章行業注意事項

  • 行業趨勢
    • 需要互操作性和集成來推動創新
    • 將風險從支付方轉移到提供方
    • 對“以患者為中心的醫療保健”的需求不斷增長
    • 基於雲的 IT 解決方案
    • 醫療保健提供者的整合
  • 生態系統分析
  • ACO(Accountable Care Organization)的演變:有希望的支付改革
  • HCIT(醫療保健 IT)支出分析
    • 北美
    • 歐洲
    • 亞太地區
  • 監管分析
  • 波特五力分析
  • 專利分析
  • 相鄰市場分析
  • 案例研究
  • 主要利益相關者和採購標準
  • 重大會議和活動(2022-2023)
  • 影響客戶業務的趨勢/中斷
  • 價格分析
    • 初始費用
    • 年度維護費
  • 技術分析
    • 人工智能 (AI) 和機器學習 (ML) 的集成
    • 數據分析

第 7 章。人口健康管理市場:按組成部分

  • 簡介
  • 軟件
  • 服務

第 8 章。人口醫療保健市場:按交付方式分類

  • 簡介
  • 本地交付模式
  • 基於雲的交付模式

第 9 章人口健康管理市場:按最終用戶分類

  • 簡介
  • 醫療保健提供者
  • 醫療費用支付方
  • 其他最終用戶

第 10 章人口健康管理市場:按地區劃分

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他亞太國家
  • 拉丁美洲
  • 中東和非洲

第 11 章競爭格局

  • 簡介
  • 大公司/有影響力公司的戰略
  • 熱門健康管理市場:研發支出
  • 主要公司的利潤分析
  • 主要公司的收入評估:按地區
  • 公司評估象限
  • 映射競爭領導力:初創公司/中小企業
  • 主要公司分析
  • 競爭形勢和趨勢
    • 產品發布
    • 資本交易
    • 其他趨勢

第 12 章公司簡介

  • 主要公司
    • CERNER CORPORATION
    • ALLSCRIPTS HEALTHCARE SOLUTIONS
    • IBM CORPORATION
    • EPIC SYSTEMS CORPORATION
    • KONINKLIJKE PHILIPS
    • I2I POPULATION HEALTH
    • HEALTH CATALYST
    • OPTUM INC. (UNITEDHEALTH GROUP子會社)
    • ENLI HEALTH INTELLIGENCE (A CEDAR GROUP TECHNOLOGIES)
    • ECLINICALWORKS
    • HEALTHEC, LLC
    • MEDECISION
    • ARCADIA
    • ATHENAHEALTH
    • COTIVITI (VERSCEND TECHNOLOGIES)
    • NEXTGEN HEALTHCARE, INC.
  • 其他企業
    • CONIFER HEALTH SOLUTIONS
    • SPH ANALYTICS
    • LIGHTBEAM HEALTH SOLUTIONS
    • INNOVACCER
    • LUMERIS
    • ZEOMEGA
    • HGS HEALTHCARE, LLC
    • PERSIVIA
    • COLOR HEALTH, INC.

第13章 附錄

簡介目錄
Product Code: HIT 2429

The global population health management market is projected to reach USD 53.3 billion by 2027 from USD 27.8 billion in 2022, at a CAGR of 13.9% during the forecast period. Growth in this market is driven by the growing government initiatives to improve community health, increasing patient pool, rising geriatric population and the growing need to curtail healthcare costs. However, lack of skilled IT professionals & high infrastructural investments are expected to restrain the growth of this market to a certain extent.

"The software segment is projected to be the largest segment& register the highest growth in the population health management market, by component"

Based on the component, the software segment is projected to be the largest segment& register the highest growth during the forecast period. Factors responsible for the growth of this segment is the increased adoption of software pertaining to improved operational efficiency, no upfront capital investment for hardware, enhanced patient engagement.

"Healthcare Providers was the largest segment by the end user of population health management market in 2021"

Healthcare providers segment is projected to grow at the highest growth rate in the population health management market in 2021. Growing need to curtail healthcare costs, rising need for better financial outcomes, ACA mandates is expected to drive the demand for population health management services in the coming years.

"APAC to witness the highest growth rate during the forecast period."

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as the improving healthcare infrastructure, growing medical tourism, government initiatives for the adoption of HCIT, increasing healthcare expenditure, and the rising purchasing power of consumers will also propel market growth.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1:40%, Tier 2: 35%, and Tier 3: 25%
  • By Designation - C-level: 25%, Director-level: 55%,and Others: 20%
  • By Region - North America: 40%,Europe: 25%,AsiaPacific: 20%, Latin America: 10%,and Middle East & Africa: 5%.

Key players in the Population Health Management Market

The key players operating in the population health management market includeCerner Corporation (US), Epic Systems Corporation (US), Koninklijke Philips (Netherlands), i2i Population Health (US), Health Catalyst (US), Optum (US), Enli Health Intelligence (US), eClinicalWorks (US), Allscripts Healthcare Solutions (US), IBM Corporation (US), HealthEC LLC (US), Medecision (US), Arcadia (US), athenahealth (US), Cotiviti (US), NextGen Healthcare, Inc. (US), Conifer Health Solutions (US), SPH Analytics (US), Lightbeam Health Solutions (US), Innovaccer (US).

Research Coverage:

The report analyses the population health management market and aims to estimate the market size and future growth potential of various market segments, based on components, delivery mode, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 POPULATION HEALTH MANAGEMENT MARKET
    • FIGURE 2 REGIONAL SEGMENTS COVERED
    • 1.2.3 YEARS CONSIDERED
  • 1.3 CURRENCY CONSIDERED
    • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • 1.4 STAKEHOLDERS
  • 1.5 LIMITATIONS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 3 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 4 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Insights from primary experts
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
    • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 APPROACH 1: BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
    • FIGURE 7 BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
    • FIGURE 8 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
    • 2.2.2 APPROACH 2: TOP-DOWN APPROACH (SUPPLY SIDE ANALYSIS)
    • FIGURE 9 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: POPULATION HEALTH MANAGEMENT MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 11 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 14 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 POPULATION HEALTH MANAGEMENT MARKET OVERVIEW
    • FIGURE 15 NEED TO CURTAIL ESCALATING HEALTHCARE COSTS TO DRIVE MARKET
  • 4.2 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER AND COUNTRY (2021)
    • FIGURE 16 JAPAN DOMINATED ASIA PACIFIC MARKET IN 2021
  • 4.3 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • 4.4 REGIONAL MIX: POPULATION HEALTH MANAGEMENT MARKET (2022-2027)
    • FIGURE 18 NORTH AMERICA TO DOMINATE GLOBAL MARKET DURING FORECAST PERIOD
  • 4.5 POPULATION HEALTH MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • TABLE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS
    • FIGURE 20 POPULATION HEALTH MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Government mandates and support for healthcare IT solutions
      • 5.2.1.2 Need to curtail escalating healthcare costs
    • FIGURE 21 US HEALTHCARE SPENDING, 2012-2020 (USD BILLION)
      • 5.2.1.3 Rising geriatric population and subsequent growth in chronic disease burden
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High investments in infrastructure to set up robust PHM program
      • 5.2.2.2 Rising data breach concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing importance of emerging markets in healthcare sector
      • 5.2.3.2 Rising focus on personalized medicine
      • 5.2.3.3 Increasing focus on value-based medicine
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of data management capabilities and skilled analysts
      • 5.2.4.2 Interoperability issues

6 INDUSTRY INSIGHTS

  • 6.1 INDUSTRY TRENDS
    • 6.1.1 NEED FOR INTEROPERABILITY AND INTEGRATION TO DRIVE INNOVATION
    • 6.1.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
    • 6.1.3 GROWING DEMAND FOR PATIENT-CENTRIC HEALTHCARE
    • FIGURE 22 VALUE-BASED CARE WORKFLOW
    • 6.1.4 CLOUD-BASED IT SOLUTIONS
    • 6.1.5 CONSOLIDATION OF HEALTHCARE PROVIDERS
  • 6.2 ECOSYSTEM ANALYSIS
    • FIGURE 23 POPULATION HEALTH MANAGEMENT MARKET: ECOSYSTEM ANALYSIS
  • 6.3 EVOLUTION OF ACOS: A PROMISING PAYMENT REFORM
    • 6.3.1 INTRODUCTION
    • FIGURE 24 ACOS: REIMBURSEMENT MODEL
    • 6.3.2 US: EVOLUTION OF ACOS
    • FIGURE 25 EVOLUTION OF ACO MODELS
    • 6.3.3 ROLE OF INFORMATION TECHNOLOGY IN ACCOUNTABLE CARE
    • FIGURE 26 ACCOUNTABLE CARE SOLUTIONS AND THEIR USE
  • 6.4 HCIT EXPENDITURE ANALYSIS
    • 6.4.1 NORTH AMERICA
    • TABLE 4 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY
    • 6.4.2 EUROPE
    • 6.4.3 ASIA PACIFIC
    • TABLE 5 JAPAN: HEALTHCARE IT INITIATIVES AND FUNDING
    • TABLE 6 CHINA: HEALTHCARE IT INITIATIVES AND FUNDING
  • 6.5 REGULATORY ANALYSIS
    • 6.5.1 NORTH AMERICA
    • 6.5.2 EUROPE
    • 6.5.3 ASIA PACIFIC
  • 6.6 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 27 DEGREE OF COMPETITION TO BE HIGH IN POPULATION HEALTH MANAGEMENT MARKET
    • TABLE 7 POPULATION HEALTH MANAGEMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 6.7 PATENT ANALYSIS
    • FIGURE 28 TOP PATENT OWNERS AND APPLICANTS FOR POPULATION HEALTH MANAGEMENT SOLUTIONS (JANUARY 2011-SEPTEMBER 2022)
    • FIGURE 29 PATENT ANALYSIS: POPULATION HEALTH MANAGEMENT MARKET (JANUARY 2017-SEPTEMBER 2022)
  • 6.8 ADJACENT MARKET ANALYSIS
    • FIGURE 30 PATIENT REGISTRY SOFTWARE MARKET: MARKET OVERVIEW
    • FIGURE 31 AMBULATORY EHR MARKET: MARKET OVERVIEW
  • 6.9 CASE STUDY
  • 6.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
    • TABLE 8 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR DEPLOYMENT MODES (%)
    • 6.10.2 BUYING CRITERIA
    • FIGURE 33 KEY BUYING CRITERIA FOR DEPLOYMENT MODES
    • TABLE 9 KEY BUYING CRITERIA FOR DEPLOYMENT MODES
  • 6.11 KEY CONFERENCES AND EVENTS (2022-2023)
  • 6.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 34 REVENUE SHIFT IN POPULATION HEALTH MANAGEMENT MARKET
  • 6.13 PRICING ANALYSIS
    • 6.13.1 INITIAL FEES
    • TABLE 10 PRE-ELEMENT FEE FOR PHM SOLUTIONS
    • 6.13.2 ANNUAL MAINTENANCE FEES
    • TABLE 11 ANNUAL MAINTENANCE FEE FOR PHM SOLUTIONS
  • 6.14 TECHNOLOGY ANALYSIS
    • 6.14.1 INTEGRATION OF AI AND ML
    • 6.14.2 DATA ANALYTICS

7 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT

  • 7.1 INTRODUCTION
    • TABLE 12 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
  • 7.2 SOFTWARE
    • 7.2.1 SOFTWARE TO DOMINATE COMPONENT SEGMENT
    • TABLE 13 POPULATION HEALTH MANAGEMENT SOFTWARE OFFERED BY KEY PLAYERS
    • TABLE 14 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 SERVICES
    • 7.3.1 INDISPENSABLE AND RECURRING NATURE OF SERVICES TO PROPEL MARKET
    • TABLE 15 POPULATION HEALTH MANAGEMENT SERVICES OFFERED BY KEY PLAYERS
    • TABLE 16 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

8 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY

  • 8.1 INTRODUCTION
    • TABLE 17 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
  • 8.2 ON-PREMISE MODE OF DELIVERY
    • 8.2.1 TRADITIONAL ON-PREMISE DEPLOYMENT TO ALLOW TIME TO TEST SOFTWARE UPGRADES BEFORE IMPLEMENTATION
    • TABLE 18 ON-PREMISE MODE OF DELIVERY: PROS AND CONS
    • TABLE 19 POPULATION HEALTH MANAGEMENT MARKET FOR ON-PREMISE SOLUTIONS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 CLOUD-BASED MODE OF DELIVERY
    • 8.3.1 CLOUD-BASED DELIVERY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
    • TABLE 20 CLOUD-BASED MODE OF DELIVERY: PROS AND CONS
    • TABLE 21 POPULATION HEALTH MANAGEMENT MARKET FOR CLOUD-BASED SOLUTIONS, BY COUNTRY, 2020-2027 (USD MILLION)

9 POPULATION HEALTH MANAGEMENT MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 22 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.2 HEALTHCARE PROVIDERS
    • 9.2.1 NEED TO IMPROVE PROFITABILITY OF HEALTHCARE OPERATIONS TO BOOST MARKET
    • TABLE 23 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.3 HEALTHCARE PAYERS
    • 9.3.1 INCREASED FOCUS ON OUTCOME-BASED PAYMENT MODELS TO STIMULATE DEMAND FOR PHM SOLUTIONS
    • TABLE 24 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.4 OTHER END USERS
    • TABLE 25 POPULATION HEALTH MANAGEMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)

10 POPULATION HEALTH MANAGEMENT MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 26 POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 35 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
    • TABLE 27 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 28 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 29 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 30 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 US to dominate North American market during forecast period
    • TABLE 31 US: MACROECONOMIC INDICATORS
    • TABLE 32 US: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 33 US: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 34 US: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Deployment of digital health initiatives to boost market
    • TABLE 35 CANADA: MACROECONOMIC INDICATORS
    • TABLE 36 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 37 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 38 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 39 EUROPE: E-HEALTH PRIORITIES FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019
    • TABLE 40 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 41 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 42 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 43 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany to dominate European population health management market
    • TABLE 44 GERMANY: MACROECONOMIC INDICATORS
    • TABLE 45 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 46 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 47 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Increasing public-private initiatives to support adoption of PHM solutions
    • TABLE 48 UK: MACROECONOMIC INDICATORS
    • TABLE 49 UK: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 50 UK: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 51 UK: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Increasing patient volume for chronic and age-related conditions to fuel market
    • TABLE 52 FRANCE: MACROECONOMIC INDICATORS
    • TABLE 53 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 54 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 55 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Government initiatives to support market
    • TABLE 56 ITALY: MACROECONOMIC INDICATORS
    • TABLE 57 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 58 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 59 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Demand for e-prescriptions and better patient record management to drive adoption of PHM solutions
    • TABLE 60 SPAIN: MACROECONOMIC INDICATORS
    • TABLE 61 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 62 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 63 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 64 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 65 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 66 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 36 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
    • TABLE 67 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 68 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 69 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 70 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Japan accounted for largest share of Asia Pacific market in 2021
    • TABLE 71 JAPAN: MACROECONOMIC INDICATORS
    • TABLE 72 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 73 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 74 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Strong government support to propel market
    • TABLE 75 CHINA: MACROECONOMIC INDICATORS
    • TABLE 76 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 77 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 78 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Growing volume of patient data generated within healthcare systems to drive market
    • TABLE 79 INDIA: MACROECONOMIC INDICATORS
    • TABLE 80 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 81 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 82 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 83 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 84 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 85 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 BRAZIL, ARGENTINA, AND MEXICO TO EMERGE AS POTENTIAL HEALTHCARE MARKETS
    • TABLE 86 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 87 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 88 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE TO PROPEL MARKET
    • TABLE 89 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 90 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020-2027 (USD MILLION)
    • TABLE 91 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • FIGURE 37 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2019 AND AUGUST 2022
  • 11.3 POPULATION HEALTH MANAGEMENT MARKET: R&D EXPENDITURE
    • FIGURE 38 R&D EXPENDITURE OF KEY PLAYERS (2020 VS. 2021)
  • 11.4 REVENUE ANALYSIS OF KEY PLAYERS
    • FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS (2021)
  • 11.5 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
    • FIGURE 40 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC REVENUE MIX
  • 11.6 COMPANY EVALUATION QUADRANT
    • 11.6.1 STARS
    • 11.6.2 EMERGING LEADERS
    • 11.6.3 PERVASIVE PLAYERS
    • 11.6.4 PARTICIPANTS
    • FIGURE 41 COMPETITIVE LEADERSHIP MAPPING, 2020
  • 11.7 COMPETITIVE LEADERSHIP MAPPING - START-UPS/SMES
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 RESPONSIVE COMPANIES
    • 11.7.3 DYNAMIC COMPANIES
    • 11.7.4 STARTING BLOCKS
    • FIGURE 42 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
  • 11.8 KEY PLAYERS ANALYSIS
    • TABLE 92 POPULATION HEALTH MANAGEMENT MARKET ANALYSIS, BY VENDOR TYPE
  • 11.9 COMPETITIVE SITUATIONS AND TRENDS
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS
    • 11.9.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 CERNER CORPORATION
    • TABLE 93 CERNER CORPORATION: COMPANY OVERVIEW
    • FIGURE 43 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.2 ALLSCRIPTS HEALTHCARE SOLUTIONS
    • TABLE 94 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY OVERVIEW
    • FIGURE 44 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2021)
    • 12.1.3 IBM CORPORATION
    • TABLE 95 IBM CORPORATION: COMPANY OVERVIEW
    • FIGURE 45 IBM CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.4 EPIC SYSTEMS CORPORATION
    • TABLE 96 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
    • 12.1.5 KONINKLIJKE PHILIPS
    • TABLE 97 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 46 PHILLIPS HEALTHCARE: COMPANY SNAPSHOT (2021)
    • 12.1.6 I2I POPULATION HEALTH
    • TABLE 98 I2I POPULATION HEALTH: COMPANY OVERVIEW
    • 12.1.7 HEALTH CATALYST
    • TABLE 99 HEALTH CATALYST: COMPANY OVERVIEW
    • FIGURE 47 HEALTH CATALYST: COMPANY SNAPSHOT (2021)
    • 12.1.8 OPTUM INC. (A SUBSIDIARY OF UNITEDHEALTH GROUP)
    • TABLE 100 OPTUM, INC: COMPANY OVERVIEW
    • FIGURE 48 OPTUM: COMPANY SNAPSHOT (2021)
    • 12.1.9 ENLI HEALTH INTELLIGENCE (A CEDAR GROUP TECHNOLOGIES)
    • TABLE 101 ENLI HEALTH INTELLIGENCE: COMPANY OVERVIEW
    • 12.1.10 ECLINICALWORKS
    • TABLE 102 ECLINICALWORKS: COMPANY OVERVIEW
    • 12.1.11 HEALTHEC, LLC
    • TABLE 103 HEALTHEC LLC: COMPANY OVERVIEW
    • 12.1.12 MEDECISION
    • TABLE 104 MEDECISION: COMPANY OVERVIEW
    • 12.1.13 ARCADIA
    • TABLE 105 ARCADIA: COMPANY OVERVIEW
    • 12.1.14 ATHENAHEALTH
    • TABLE 106 ATHENAHEALTH, INC: COMPANY OVERVIEW
    • 12.1.15 COTIVITI (VERSCEND TECHNOLOGIES)
    • TABLE 107 COTIVITI: COMPANY OVERVIEW
    • 12.1.16 NEXTGEN HEALTHCARE, INC.
    • TABLE 108 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW
    • FIGURE 49 NEXTGEN HEALTHCARE: COMPANY SNAPSHOT (2021)
  • 12.2 OTHER PLAYERS
    • 12.2.1 CONIFER HEALTH SOLUTIONS
    • 12.2.2 SPH ANALYTICS
    • 12.2.3 LIGHTBEAM HEALTH SOLUTIONS
    • 12.2.4 INNOVACCER
    • 12.2.5 LUMERIS
    • 12.2.6 ZEOMEGA
    • 12.2.7 HGS HEALTHCARE, LLC
    • 12.2.8 PERSIVIA
    • 12.2.9 COLOR HEALTH, INC.
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS